Gazyva and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Gazyva (obinutuzumab), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Venclexta, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Gazyva. It is created by eHealthMe based on reports of 4,466 people who have side effects when taking Gazyva from the FDA, and is updated regularly.

What is Gazyva?

Gazyva has active ingredients of obinutuzumab. eHealthMe is studying from 4,470 Gazyva users. Check the latest studies of Gazyva.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,836 drugs and 4,493 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Jul, 18, 2026

4,466 people reported to have side effects when taking Gazyva.
Among them, 29 people (0.65%) have Acute kidney failure.

Could Gazyva cause Acute kidney failure?

Among these 29 people:

How long have people been on Gazyva when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Gazyva? *

female: 22.73 %
male: 77.27 %

What is the age of people who have Acute kidney failure when taking Gazyva? *

What are other drugs people take besides Gazyva? *

What are other side effects people have besides Acute kidney failure? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 13.79%
Drug Ineffective: 4 people, 13.79%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 10.34%
Pathological Fracture (broken bone caused by disease): 3 people, 10.34%
Pneumonia: 3 people, 10.34%
Chills (felling of cold): 2 people, 6.90%
Dizziness: 2 people, 6.90%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 6.90%
Perioral Dermatitis (facial rash that causes bumps to develop around the mouth): 2 people, 6.90%
Nausea (feeling of having an urge to vomit): 2 people, 6.90%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 12 people, 41.38%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 10.34%
Nephropathy (damage to or disease of a kidney): 3 people, 10.34%
Nausea And Vomiting: 3 people, 10.34%
Nausea (feeling of having an urge to vomit): 3 people, 10.34%
Erection Problems: 3 people, 10.34%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 10.34%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 6.90%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 6.90%
Lymphoma (cancer that begins in immune system cells): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Gazyva and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gazyva:

Gazyva (4,470 reports)

Browse all side effects of Gazyva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,836 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,493 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on obinutuzumab (the active ingredients of Gazyva) and Gazyva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.